Update on pyrin functions and mechanisms of familial mediterranean fever

Frontiers in Microbiology

Volumn 7, Issue MAR, 2016, Pages

  Manukyan, Gayane ^a   Aminov, Rustam ^b  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Autoinflammation; Cytoskeleton; Familial Mediterranean fever; Innate immunity; Pyrin

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PYRIN; SERUM AMYLOID A; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMYLOIDOSIS; AUTOPHAGY; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SENSITIVITY ANALYSIS;

EID: 84964318604     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00456     Document Type: Review

References (97)

1. Akkoc, N., Sari, I., Akar, S., Binicier, O., Thomas, M. G., Weale, M. E., et al. (2010). Increased prevalence of M694V in patients with ankylosing spondylitis: additional evidence for a link with familial Mediterranean fever. Arthritis Rheum. 62, 3059-3063. doi: 10.1002/art.27598
2. Aksu, K., and Keser, G. (2011). Coexistence of vasculitides with familial Mediterranean fever. Rheumatol. Int. 31, 1263-1274. doi: 10.1007/s00296-011-1840-z
3. Akyuz, F., Besisik, F., Ustek, D., Ekmekçi, C., Uyar, A., Pinarbasi, B., et al. (2013). Association of the MEFV gene variations with inflammatory bowel disease in Turkey. J. Clin. Gastroenterol. 47, e23-e27. doi: 10.1097/MCG.0b013e3182597992
4. Arostegui, J. I., Arnal, C., Merino, R., Modesto, C., Antonia, C. M., Moreno, P., et al. (2007). NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum. 56, 3805-3813. doi: 10.1002/art.22966
5. Atagunduz, P., Ergun, T., and Direskeneli, H. (2003). MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clin. Exp. Rheumatol. 21(4 Suppl. 30), S35-S37.
6. Ben-Chetrit, E., Bergmann, S., and Sood, R. (2006). Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis. Rheumatology (Oxford) 45, 274-282. doi: 10.1093/rheumatology/kei140
7. Ben-Chetrit, E., and Levy, M. (1998). Familial Mediterranean fever. Lancet 351, 659-664. doi: 10.1016/S0140-6736(97)09408-7
8. Ben-Zvi, I., Herskovizh, C., Kukuy, O., Kassel, Y., Grossman, C., and Livneh, A. (2015). Familial Mediterranean fever without MEFV mutations: a case-control study. Orphanet J. Rare Dis. 10, 34. doi: 10.1186/s13023-015-0252-7
9. Ben-Zvi, I., and Livneh, A. (2014). Colchicine failure in familial Mediterranean fever and potential alternatives: embarking on the anakinra trial. Isr. Med. Assoc. J. 16, 271-273.
10. Bodar, E. J., van der Hilst, J. C., Drenth, J. P., van der Meer, J. W., and Simon, A. (2005). Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth. J. Med. 63, 260-264.
11. Booty, M. G., Chae, J. J., Masters, S. L., Remmers, E. F., Barham, B., Le, J. M., et al. (2009). Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum. 60, 1851-1861. doi: 10.1002/art.24569
12. Brenner-Ullman, A., Melzer-Ofir, H., Daniels, M., and Shohat, M. (1994). Possible protection against asthma in heterozygotes for familial Mediterranean fever. Am. J. Med. Genet. 2, 172-175. doi: 10.1002/ajmg.1320530210
13. Brydges, S., and Kastner, D. L. (2006). The systemic autoinflammatory diseases: inborn errors of the innate immune system. Curr. Top. Microbiol. Immunol. 305, 127-160.
14. Cattan, D. (2003). Familial Mediterranean fever: is low mortality from tuberculosis a specific advantage for MEFV mutations carriers? Mortality from tuberculosis among Muslims, Jewish, French, Italian and Maltese patients in StateTunis (Tunisia) in the first half of the 20th century. Clin. Exp. Rheumatol. 4(Suppl. 30), S53-S54.
15. Centola, M., Wood, G., Frucht, D. M., Galon, J., Aringer, M., Farrell, C., et al. (2000). The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 95, 3223-3231.
16. Chae, J. J., Cho, Y. H., Lee, G. S., Cheng, J., Liu, P. P., Feigenbaum, L., et al. (2011). Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity 34, 755-768. doi: 10.1016/j.immuni.2011.02.020
17. Chae, J. J., Wood, G., Masters, S. L., Richard, K., Park, G., Smith, B. J., et al. (2006). The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc. Natl. Acad. Sci. U.S.A. 103, 9982-9987. doi: 10.1073/pnas.0602081103
18. Chae, J. J., Wood, G., Richard, K., Jaffe, H., Colburn, N. T., Masters, S. L., et al. (2008). The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 112, 1794-1803. doi: 10.1182/blood-2008-01-134932
19. Daniels, M., Shohat, T., Brenner-Ullman, A., and Shohat, M. (1995). Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel. Am. J. Med. Genet. 55, 311-314. doi: 10.1002/ajmg.1320550313
20. Dewalle, M., Domingo, C., Rozenbaum, M., Ben-Chétrit, E., Cattan, D., Bernot, A., et al. (1998). Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur. J. Hum. Genet. 6, 95-97. doi: 10.1038/sj.ejhg.5200170
21. Dinarello, C. A., Chusid, M. J., Fauci, A. S., Gallin, J. I., Dale, D. C., and Wolff, S. M. (1976). Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever. Arthritis Rheum. 19, 618-622. doi: 10.1002/art.1780190315
22. Dumas, A., Amiable, N., de Rivero Vaccari, J. P., Chae, J. J., Keane, R. W., Lacroix, S., et al. (2014). The inflammasome pyrin contributes to pertussis toxin-induced IL-1β synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis. PLoS Pathog. 10:e1004150. doi: 10.1371/journal.ppat.1004150
23. Endlich, N., Kress, K. R., Reiser, J., Uttenweiler, D., Kriz, W., Mundel, P., et al. (2001). Podocytes respond to mechanical stress in vitro. J. Am. Soc. Nephrol. 12, 413-422.
24. Feng, J., Zhang, Z., Li, W., Shen, X., Song, W., Yang, C., et al. (2009). Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels. PLoS ONE 4:e8480. doi: 10.1371/journal.pone.0008480
25. Foley, J. F. (2014). Detecting a pathogenic activity, not a pathogenic molecule. Sci. Signal. 7:ec252. doi: 10.1126/scisignal.2005897
26. Fumagalli, M., Cagliani, R., Pozzoli, U., Riva, S., Comi, G. P., Menozzi, G., et al. (2009). A population genetics study of the familial Mediterranean fever gene: evidence of balancing selection under an overdominance regime. Genes Immun. 10, 678-686. doi: 10.1038/gene.2009.59
27. Gattorno, M., Pelagatti, M. A., Meini, A., Obici, L., Barcellona, R., Federici, S., et al. (2008). Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 58, 1516-1520. doi: 10.1002/art.23475
28. Gavrilin, M. A., Abdelaziz, D. H., Mostafa, M., Abdulrahman, B. A., Grandhi, J., Akhter, A., et al. (2012). Activation of the pyrin inflammasome by intracellular Burkholderia cenocepacia. J. Immunol. 188, 3469-3477. doi: 10.4049/jimmunol.1102272
29. Gershoni-Baruch, R., Broza, Y., and Brik, R. (2003). Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. J. Pediatr. 143, 658-661. doi: 10.1067/S0022-3476(03)00502-X
30. Gershoni-Baruch, R., Shinawi, M., Leah, K., Badarnah, K., and Brik, R. (2001). Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur. J. Hum. Genet. 9, 634-637. doi: 10.1038/sj.ejhg.5200672
31. Giaglis, S., Mimidis, K., Papadopoulos, V., Thomopoulos, K., Sidiropoulos, P., Rafail, S., et al. (2006). Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect? Dig. Dis. Sci. 51, 687-692. doi: 10.1007/s10620-006-3192-1
32. Gumucio, D. L., Diaz, A., Schaner, P., Richards, N., Babcock, C., Schaller, M., et al. (2002). Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis. Clin. Exp. Rheumatol. 20(Suppl. 26), S45-S53.
33. Hesker, P. R., Nguyen, M., Kovarova, M., Ting, J. P., and Koller, B. H. (2012). Genetic loss of murine pyrin, the Familial Mediterranean Fever protein, increases interleukin-1beta levels.ponents and inhibits proIL-1beta processing. PLoS ONE 7:e511056. doi: 10.1371/journal.pone.0051105
34. Honing, H., van den Berg, T. K., van der Pol, S. M., Dijkstra, C. D., van der Kammen, R. A., Collard, J. G., et al. (2004). RhoA activation promotes transendothelial migration of monocytes via ROCK. J. Leukoc. Biol. 75, 523-528. doi: 10.1189/jlb.0203054
35. Kalyoncu, M., Acar, B. C., Cakar, N., Bakkaloglu, A., Ozturk, S., Dereli, E., et al. (2006). Are carriers for MEFV mutations "healthy?" Clin. Exp. Rheumatol. 24(5 Suppl. 42), S120-S122.
36. Kim, M. L., Chae, J. J., Park, Y. H., De Nardo, D., Stirzaker, R. A., Ko, H. J., et al. (2015). Aberrant actin depolymerization triggers the pyrin inflammasome and autoinflammatory disease that is dependent on IL-18, not IL-1β. J. Exp. Med. 212, 927-938. doi: 10.1084/jem.20142384
37. Kimura, T., Jain, A., Choi, S. W., Mandell, M. A., Schroder, K., Johansen, T., et al. (2015). TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. J. Cell Biol. 210, 973-989. doi: 10.1083/jcb.201503023
38. Kohl, A., and Gruütter, M. G. (2004). Fire and death: the pyrin domain joins the death-domain superfamily. C. R. Biol. 327, 1077-1086. doi: 10.1016/j.crvi.2004.08.006
39. Kuijk, L. M., Govers, A. M., Frenkel, J., and Hofhuis, W. J. (2007). Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra. Ann. Rheum. Dis. 66, 1545-1546. doi: 10.1136/ard.2007.071498
40. La Regina, M., Nucera, G., Diaco, M., Procopio, A., Gasbarrini, G., Notarnicola, C., et al. (2003). Familial Mediterranean fever is no longer a rare disease in Italy. Eur. J. Hum. Genet. 11, 50-56. doi: 10.1038/sj.ejhg.5200916
41. Lidar, M., Yaqubov, M., Zaks, N., Ben-Horin, S., Langevitz, P., and Livneh, A. (2006). The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J. Rheumatol. 33, 1089-1092.
42. Mandell, M. A., Jain, A., Arko-Mensah, J., Chauhan, S., Kimura, T., Dinkins, C., et al. (2014). TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev. Cell 30, 394-409. doi: 10.1016/j.devcel.2014.06.013
43. Mankan, A. K., Kubarenko, A., and Hornung, V. (2012). Immunology in clinic review series; focus on autoinflammatory diseases: inflammasomes: mechanisms of activation. Clin. Exp. Immunol. 167, 369-381. doi: 10.1111/j.1365-2249.2011.04534.x
44. Mansfield, E., Chae, J. J., Komarow, H. D., Brotz, T. M., Frucht, D. M., Aksentijevich, I., et al. (2001). The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood 98, 851-859. doi: 10.1182/blood.V98.3.851
45. Manukyan, G., Petrek, M., Kriegova, E., Ghazaryan, K., Fillerova, R., and Boyajyan, A. (2013a). Activated phenotype of circulating neutrophils in familial Mediterranean fever. Immunobiology 218, 892-898. doi: 10.1016/j.imbio.2012.10.007
46. Manukyan, G., Petrek, M., Tomankova, T., Martirosyan, A., Tatyan, M., Navratilova, Z., et al. (2013b). Colchicine modulates expression of pro-inflammatory genes in neutrophils from patients with familial Mediterranean fever and healthy subjects. J. Biol. Regul. Homeost. Agents 27, 329-336.
47. Marek-Yagel, D., Berkun, Y., Padeh, S., Abu, A., Reznik-Wolf, H., Livneh, A., et al. (2009). Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum. 60, 1862-1866. doi: 10.1002/art.24570
48. Martinon, F., Hofmann, K., and Tschopp, J. (2001). The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr. Biol. 11, R118-R120. doi: 10.1016/S0960-9822(01)00056-2
49. Masters, S. L., Simon, A., Aksentijevich, I., and Kastner, D. L. (2009). Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu. Rev. Immunol. 27, 621-628. doi: 10.1146/annurev.immunol.25.022106.141627
50. Matthews, B. D., Overby, D. R., Mannix, R., and Ingber, D. E. (2006). Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels. J. Cell Sci. 119, 508-518. doi: 10.1242/jcs.02760
51. McDermott, M. F., Aksentijevich, I., Galon, J., McDermott, E. M., Ogunkolade, B. W., Centola, M., et al. (1999). Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97, 133-144. doi: 10.1016/S0092-8674(00)80721-7
52. Nakamura, A., Matsuda, M., Tazawa, K., Shimojima, Y., and Ikeda, S. (2007). Successful treatment with infliximab and low-dose methotrexate in a Japanese patient with familial Mediterranean fever. Int. Med. 46, 1247-1249. doi: 10.2169/internalmedicine.46.0064
53. Omenetti, A., Carta, S., Delfino, L., Martini, A., Gattorno, M., and Rubartelli, A. (2014). Increased NLRP3-dependent interleukin 1β secretion in patients with familial Mediterranean fever: correlation with MEFV genotype. Ann. Rheum. Dis. 73, 462-469. doi: 10.1136/annrheumdis-2012-202774
54. Papadopoulos, V. P., Giaglis, S., Mitroulis, I., and Ritis, K. (2008). The population genetics of familial mediterranean fever: a meta-analysis study. Ann. Hum. Genet. 72, 752-761. doi: 10.1111/j.1469-1809.2008.00471.x
55. Papin, S., Cuenin, S., Agostini, L., Martinon, F., Werner, S., Beer, H. D., et al. (2007). The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death. Differ. 14, 1457-1466. doi: 10.1038/sj.cdd.4402142
56. Papin, S., Duquesnoy, P., Cazeneuve, C., Pantel, J., Coppey-Moisan, M., Dargemont, C., et al. (2000). Alternative splicing at the MEFV locus involved in familial Mediterranean fever regulates translocation of the marenostrin/pyrin protein to the nucleus. Hum. Mol. Genet. 9, 3001-3009. doi: 10.1093/hmg/9.20.3001
57. Park, Y., Kastner, D., and Chae, J. (2015). Activation of the pyrin inflammasome through the RhoA signaling pathway in FMF and HIDS. Pediatric Rheumatol. Online J. 13(Suppl. 1), O11. doi: 10.1186/1546-0096-13-S1-O11
58. Perfetto, L., Gherardini, P. F., Davey, N. E., Diella, F., Helmer-Citterich, M., and Cesareni, G. (2013). Exploring the diversity of SPRY/B30.2-mediated interactions. Trends Biochem. Sci. 38, 38-46. doi: 10.1016/j.tibs.2012.10.001
59. Pras, M. (1998). Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene. Scand. J. Rheumatol. 27, 92-97. doi: 10.1080/030097498440949
60. Provenzano, P. P., and Keely, P. J. (2011). Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J. Cell Sci. 124, 1195-1205. doi: 10.1242/jcs.067009
61. Rabinovich, E., Livneh, A., Langevitz, P., Brezniak, N., Shinar, E., Pras, M., et al. (2005). Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann. Rheum. Dis. 64, 1009-1014. doi: 10.1136/ard.2004.029447
62. Richards, N., Schaner, P., Diaz, A., Stuckey, J., Shelden, E., Wadhwa, A., et al. (2001). Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J. Biol. Chem. 276, 39320-39329. doi: 10.1074/jbc.M104730200
63. Ross, J. J. (2007). Goats, germs, and fever: are the pyrin mutations responsible for familial Mediterranean fever protective against Brucellosis? Med. Hypotheses 3, 499-501. doi: 10.1016/j.mehy.2006.07.027
64. Sackesen, C., Bakkaloglu, A., Sekerel, B. E., Ozaltin, F., Besbas, N., Yilmaz, E., et al. (2004). Decreased prevalence of atopy in paediatric patients with familial Mediterranean fever. Ann. Rheum. Dis. 2, 187-190. doi: 10.1136/ard.2003.007013
65. Sackett, D. L., and Varma, J. K. (1993). Molecular mechanism of colchicine action: induced local unfolding of beta-tubulin. Biochemistry 32, 13560-13565. doi: 10.1021/bi00212a023
66. Sarkisian, T., Ajrapetian, H., Beglarian, A., Shahsuvarian, G., and Egiazarian, A. (2008). Familial Mediterranean Fever in armenian population. Georgian Med. News 156, 105-111.
67. Schaner, P., Richards, N., Wadhwa, A., Aksentijevich, I., Kastner, D., Tucker, P., et al. (2001). Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states. Nat. Genet. 27, 318-321. doi: 10.1038/85893
68. Seshadri, S., Duncan, M. D., Hart, J. M., Gavrilin, M. A., and Wewers, M. D. (2007). Pyrin levels in human monocytes and monocyte-derived macrophages regulate IL-1beta processing and release. J. Immunol. 179, 1274-1281. doi: 10.4049/jimmunol.179.2.1274
69. Shinar, Y., Livneh, A., Langevitz, P., Zaks, N., Aksentijevich, I., Koziol, D. E., et al. (2000). Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J. Rheumatol. 27, 1703-1707.
70. Shoham, N. G., Centola, M., Mansfield, E., Hull, K. M., Wood, G., Wise, C. A., et al. (2003). Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc. Natl. Acad. Sci. U.S.A. 100, 13501-13506. doi: 10.1073/pnas.2135380100
71. Shohat, M., and Halpern, G. J. (2011). Familial Mediterranean fever-a review. Genet. Med. 13, 487-498. doi: 10.1097/GIM.0b013e3182060456
72. Shohat, M., Magal, N., Shohat, T., Chen, X., Dagan, T., Mimouni, A., et al. (1999). Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur. J. Hum. Genet. 7, 287-292. doi: 10.1038/sj.ejhg.5200303
73. Sohar, E., Gafni, J., Pras, M., and Heller, H. (1967). A survey of 470 cases and review of the literature. Am. J. Med. 43, 227-253. doi: 10.1016/0002-9343(67)90167-2
74. Spiering, D., and Hodgson, L. (2011). Dynamics of the Rho-family small GTPases in actin regulation and motility. Cell Adh. Migr. 5, 170-180. doi: 10.4161/cam.5.2.14403
75. Sugiyama, R., Agematsu, K., Migita, K., Nakayama, J., Mokuda, S., Ogura, F., et al. (2014). Defect of suppression of inflammasome-independent interleukin-8 secretion from SW982 synovial sarcoma cells by familial Mediterranean fever-derived pyrin mutations. Mol. Biol. Rep. 41, 545-553. doi: 10.1007/s11033-013-2890-y
76. Taskiran, E. Z., Cetinkaya, A., Balci-Peynircioglu, B., Akkaya, Y. Z., and Yilmaz, E. (2012). The effect of colchicine on pyrin and pyrin interacting proteins. J. Cell Biochem. 113, 3536-3546. doi: 10.1002/jcb.24231
77. The French FMF Consortium (1997). A candidate gene for familial Mediterranean fever. Nat. Genet. 17, 25-31. doi: 10.1038/ng0997-25
78. The International FMF Consortium (1997). Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90, 797-807. doi: 10.1016/S0092-8674(00)80539-5
79. Ting, J. P., Kastner, D. L., and Hoffman, H. M. (2006). CATERPILLERs, pyrin and hereditary immunological disorders. Nat. Rev. Immunol. 6, 183-195. doi: 10.1038/nri1788
80. Touitou, I. (2001). The spectrum of familial Mediterranean fever (FMF) mutations. Eur. J. Hum. Genet. 9, 473-483. doi: 10.1038/sj.ejhg.5200658
81. Tunca, M., Akar, S., Hawkins, P. N., Booth, S. E., Sengül, B., Yavuzksen, T. U., et al. (2002). The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever. Eur. J. Hum. Genet. 10, 786-789. doi: 10.1038/sj.ejhg.5200900
82. Tunca, M., Akar, S., Onen, F., Ozdogan, H., Kasapcopur, O., Yalcinkaya, F., et al. (2005). Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84, 1-11. doi: 10.1097/01.md.0000152370.84628.0c
83. Turkcapar, N., Tuncali, T., Kutlay, S., Burhan, B. Y., Kinikli, G., Erturk, S., et al. (2007). The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever. Rheumatol. Int. 27, 545-551. doi: 10.1007/s00296-006-0255-8
84. Twig, G., Livneh, A., Vivante, A., Afek, A., Shamiss, A., Derazne, E., et al. (2014). Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents. Ann. Rheum. Dis. 73, 704-709. doi: 10.1136/annrheumdis-2012-202932
85. Uslu, N., Yüce, A., Demir, H., Saltik-Temizel, I. N., Usta, Y., Yilmaz, E., et al. (2010). The association of inflammatory bowel disease and Mediterranean fever gene (MEFV) mutations in Turkish children. Dig. Dis. Sci. 55, 3488-3494. doi: 10.1007/s10620-010-1178-5
86. Vajjhala, P. R., Kaiser, S., Smith, S. J., Ong, Q. R., Soh, S. L., Stacey, K. J., et al. (2014). Identification of multifaceted binding modes for pyrin and ASC pyrin domains gives insights into pyrin inflammasome assembly. J. Biol. Chem. 289, 23504-23519. doi: 10.1074/jbc.M114.553305
87. van der Hilst, J. C., Simon, A., and Drenth, J. P. (2005). Hereditary periodic fever and reactive amyloidosis. Clin. Exp. Med. 5, 87-98. doi: 10.1007/s10238-005-0071-6
88. Vicente-Manzanares, M., and Sánchez-Madrid, F. (2004). Role of the cytoskeleton during leukocyte responses. Nat. Rev. Immunol. 4, 110-122. doi: 10.1038/nri1268
89. Waite, A. L., Schaner, P., Hu, C., Richards, N., Balci-Peynircioglu, B., Hong, A., et al. (2009). Pyrin and ASC co-localize to cellular sites that are rich in polymerizing actin. Exp. Biol. Med. (Maywood) 234, 40-52. doi: 10.3181/0806-RM-184
90. Wang, N., Butler, J. P., and Ingber, D. E. (1993). Mechanotransduction across the cell surface and through the cytoskeleton. Science 260, 1124-1127. doi: 10.1126/science.7684161
91. Weinert, C., Morger, D., Djekic, A., Grütter, M. G., and Mittl, P. R. (2015). Crystal structure of TRIM20 C-terminal coiled-coil/B30.2 fragment: implications for the recognition of higher order oligomers. Sci. Rep. 5:10819. doi: 10.1038/srep10819
92. Xu, H., Yang, J., Gao, W., Li, L., Li, P., Zhang, L., et al. (2014). Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature 513, 237-241. doi: 10.1038/nature13449
93. Yasunami, M., Nakamura, H., Agematsu, K., Nakamura, A., Yazaki, M., Kishida, D., et al. (2015). Identification of disease-promoting HLA class I and protective class II modifiers in Japanese patients with familial Mediterranean fever. PLoS ONE 10:e0125938. doi: 10.1371/journal.pone.0125938
94. Yilmaz, E., Ozen, S., Balci, B., Duzova, A., Topaloglu, R., Besbas, N., et al. (2001). Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population. Eur. J. Hum. Genet. 9, 553-555. doi: 10.1038/sj.ejhg.5200674
95. Yu, J. W., Fernandes-Alnemri, T., Datta, P., Wu, J., Juliana, C., Solorzano, L., et al. (2007). Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol. Cell 28, 214-227. doi: 10.1016/j.molcel.2007.08.029
96. Yu, J. W., Wu, J., Zhang, Z., Datta, P., Ibrahimi, I., Taniguchi, S., et al. (2006). Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death. Dif. 13, 236-249. doi: 10.1038/sj.cdd.4401734
97. Zemer, D., Pras, M., Sohar, E., Modan, M., Cabili, S., and Gafni, J. (1986). Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N. Engl. J. Med. 314, 1001-1005. doi: 10.1056/NEJM198604173141601